Cargando…
Pharmacological reversal of the direct oral anticoagulants—A comprehensive review of the literature
ESSENTIALS: There remains clinical concern regarding the optimal management of direct oral (DOAC) anticoagulant effect for emergencies such as bleeding or urgent surgery/procedures. Idarucizumab is the preferred agent for urgent reversal of dabigatran for severe bleeding or urgent surgeries/procedur...
Autores principales: | Shaw, Joseph R., Siegal, Deborah M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055488/ https://www.ncbi.nlm.nih.gov/pubmed/30046727 http://dx.doi.org/10.1002/rth2.12089 |
Ejemplares similares
-
Considerations for use of direct oral anticoagulants in arterial disease
por: Siegal, Deborah M., et al.
Publicado: (2021) -
Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017) -
The Reversal of Direct Oral Anticoagulants in Animal Models
por: Honickel, Markus, et al.
Publicado: (2017) -
Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
por: Kustos, Stephanie A., et al.
Publicado: (2019) -
Anticoagulation for Left Ventricle Thrombus—Case Series and Literature Review for Use of Direct Oral Anticoagulants
por: Pradhan, Akshyaya, et al.
Publicado: (2023)